Multiple myeloma other diagnostic studies

Jump to navigation Jump to search

Multiple myeloma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Multiple Myeloma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

Echocardiograph and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Future or Investigational Therapies

Case Studies

Case #1

Multiple myeloma other diagnostic studies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Multiple myeloma other diagnostic studies

All Images
X-rays
Echo and Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Multiple myeloma other diagnostic studies

CDC on Multiple myeloma other diagnostic studies

Multiple myeloma other diagnostic studies in the news

Blogs on Multiple myeloma other diagnostic studies

Directions to Hospitals Treating Multiple myeloma

Risk calculators and risk factors for Multiple myeloma other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Bone Marrow Biopsy

  • A bone marrow aspiration and biopsy is a procedure in which a small amount of bone marrow and bone is removed for microscopic examination.
  • It may be done in a clinic or hospital on an outpatient or in-patient basis.
  • It is usually performed to estimate the percentage of bone marrow occupied by plasma cells.
  • Examination of abnormal plasma in the bone marrow is the only way to confirm a diagnosis.
  • The percentage of plasma cells is also used in the diagnostic criteria of multiple myeloma.
Diagnostic Criteria

In 2003, the International Myeloma Working Group agreed on diagnostic criteria for symptomatic myeloma, asymptomatic myeloma and MGUS (monoclonal gammopathy of undetermined significance):

  • Symptomatic myeloma:
    1. Clonal plasma cells >10% on bone marrow biopsy or (in any quantity) in a biopsy from other tissues (plasmacytoma)
    2. A monoclonal protein (paraprotein) in either serum or urine
    3. Evidence of end-organ damage (related organ or tissue impairment, ROTI):
  • Asymptomatic myeloma:
    1. Serum paraprotein >30 g/L AND/OR
    2. Clonal plasma cells >10% on bone marrow biopsy AND
    3. NO myeloma-related organ or tissue impairment
  • Monoclonal gammopathy of undetermined significance (MGUS):
    1. Serum paraprotein <30 g/L AND/OR
    2. Clonal plasma cells <10% on bone marrow biopsy AND
    3. NO multiple myeloma-related organ or tissue impairment

Related conditions include solitary plasmacytoma (a single tumor of plasma cells, typically treated with irradiation), plasma cell dyscrasia (where only the antibodies produce symptoms, e.g. AL amyloidosis), and POEMS syndrome (peripheral neuropathy, organomegaly, endocrinopathy, monoclonal plasma cell disorder, skin changes).

References


Template:WikiDoc Sources